FDA Limits Use of J&J Vaccine
On May 5th, the Food and Drug Administration (FDA) issued a Coronavirus Update limiting the Johnson & Johnson (J&J) COVID-19 vaccine to certain individuals age 18 and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate and to individuals age 18 and older who elect to receive the J&J vaccine because they would not otherwise receive a COVID-19 vaccine. This limitation is due to the J&J vaccine's link to rare but serious blood clots.
Individuals are recommended to instead receive mRNA vaccines (Moderna or Pfizer) for their primary and booster shots.
Contact: Meg Everett, meverett@leadingageny.org, 518-867-8871